Combined Modality TherapyRadiotherapyAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy DosageMechlorethamineProcarbazineRadiotherapy, AdjuvantChemotherapy, AdjuvantHodgkin DiseaseRadiotherapy, ConformalLomustineTreatment OutcomeCisplatinNeoplasm StagingLung NeoplasmsVincristineCyclophosphamideRadiotherapy, Intensity-ModulatedDoxorubicinSurvival AnalysisDisease-Free SurvivalRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyPrognosisSurvival RateActuarial AnalysisPrednisoneAntineoplastic AgentsDose FractionationRadiation InjuriesFollow-Up StudiesAdenocarcinomaCarcinoma, Non-Small-Cell LungRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedNeoplasm Recurrence, LocalCarcinoma, Small CellNeoadjuvant TherapyBreast NeoplasmsClinical Trials as TopicHead and Neck NeoplasmsFluorouracilEtoposideRadiation OncologyBrain NeoplasmsChemoradiotherapyCarcinoma, Squamous CellNeoplasmsDrug Administration ScheduleDose-Response Relationship, RadiationBrachytherapyRadiosurgeryVinblastineMethotrexateNasopharyngeal NeoplasmsCarboplatinTime FactorsBleomycinCranial IrradiationDacarbazineTomography, X-Ray ComputedRectal NeoplasmsSalvage TherapyAntineoplastic Agents, AlkylatingPaclitaxelInduction ChemotherapyRadiation ToleranceAntimetabolites, AntineoplasticRetrospective StudiesIfosfamideDeoxycytidineRadiation-Sensitizing AgentsNeoplasm MetastasisProspective StudiesTaxoidsPalliative CareKaplan-Meier EstimateOrgans at RiskNeoplasms, Second PrimaryProstatic NeoplasmsCarcinomaTesticular NeoplasmsLymphatic MetastasisOrganoplatinum CompoundsBone NeoplasmsDrug Resistance, NeoplasmLymphoma, Non-HodgkinMastectomy, SegmentalPelvic NeoplasmsRadiation PneumonitisParticle AcceleratorsLaryngeal NeoplasmsRadiometryRadiation DosageFeasibility StudiesSarcomaPositron-Emission TomographyRecurrenceCytarabineMastectomy